The use of n-butyl-2 cyanoacrylate as an embolic agent in the minimally invasive treatment of renal arteriovenous malformations

Ann Acad Med Singap. 2013 Apr;42(4):207-9.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Adult
  • Arteriovenous Malformations / therapy*
  • Embolization, Therapeutic / methods*
  • Enbucrilate / therapeutic use*
  • Female
  • Humans
  • Kidney / blood supply*
  • Male
  • Middle Aged

Substances

  • Enbucrilate